Medication info
Lozatine 100 mg (Losartan Potassium)

Lozatine 100 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›100mg / 1 tablet
Manufacturer / importer
HLB Pharmaceuticals Co., Ltd.
Appearance
White, droplet-shaped film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200803249 · Approved 2008.03.24 · Insurance code 647301420

Summary

Main use
Treatment of kidney disease in patients with hypertension or type 2 diabetes accompanied by hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension — Adults: The recommended initial and maintenance dose is 50 mg of losartan potassium taken orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the response is inadequate, the same total daily dose may be divided and taken orally twice daily, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Renal disease in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic medicines (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No initial dose adjustment is required in patients aged 75 years or younger. For patients over 75 years of age, an initial dose of 25 mg once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is required. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg once daily is recommended. For patients who may have reduced effective circulating blood volume (e.g., patients receiving diuretics), an initial dose of 25 mg once daily is recommended (see Precautions). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years and older weighing 20 kg or more but less than 50 kg who can swallow tablets: The recommended dose is 25 mg once daily; it may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years and older weighing 50 kg or more: The usual recommended dose is 50 mg once daily; it may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Children under 6 years of age: Not recommended. Children with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Children with hepatic impairment: Not recommended.

Ingredients

Manufacturer
HLB Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of kidney disease in patients with hypertension or type 2 diabetes accompanied by hypertension

  • Hypertension
  • kidney disease
View approved original text

This medication is used to treat hypertension. It also helps prevent or treat kidney disease due to hypertension in patients with type 2 diabetes. Therefore, it is effective in blood pressure control and kidney protection. Overall, it is used to improve complications related to hypertension.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension — Adults: The recommended initial and maintenance dose is 50 mg of losartan potassium taken orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the response is inadequate, the same total daily dose may be divided and taken orally twice daily, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Renal disease in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic medicines (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No initial dose adjustment is required in patients aged 75 years or younger. For patients over 75 years of age, an initial dose of 25 mg once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is required. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg once daily is recommended. For patients who may have reduced effective circulating blood volume (e.g., patients receiving diuretics), an initial dose of 25 mg once daily is recommended (see Precautions). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years and older weighing 20 kg or more but less than 50 kg who can swallow tablets: The recommended dose is 25 mg once daily; it may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years and older weighing 50 kg or more: The usual recommended dose is 50 mg once daily; it may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Children under 6 years of age: Not recommended. Children with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Children with hepatic impairment: Not recommended.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. People with severely impaired liver function or certain genetic lactose-related diseases should not take this medication. Elderly individuals, those with weak kidney function, and people with hyperkalemia should take this medication with caution and should have their blood pressure and blood tests monitored regularly under a doctor's directive. While taking this medication, be cautious of symptoms that may indicate excessively low blood pressure or worsening kidney function, and report any abnormalities to a doctor immediately. Avoid taking this medication with other antihypertensive drugs, potassium-sparing diuretics, or potassium supplements as they may lead to dangerously high potassium levels in the blood. If sudden dizziness, loss of consciousness, or shortness of breath occurs while taking this medication, discontinue use and consult healthcare personnel immediately. This medication can affect liver or kidney function, so regular blood tests and liver function tests are important. Women who are breastfeeding are advised not to take this medication; if it is necessary, breastfeeding should be discontinued. Children, especially those under 6 years of age or with severely impaired kidney function, should not take this medication. It is advisable to avoid grapefruit juice while taking this medication, and since it may interact with other medicines beyond hypertension treatment, it is essential to consult with a doctor or pharmacist regarding other medications being taken. Symptoms such as excessively low blood pressure, kidney failure, arrhythmias, or hypoglycemia may arise, so report these symptoms to healthcare personnel immediately. This medication should be kept out of reach of children and should not be transferred to other containers for safety.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • low back pain
  • leg pain
  • dizziness
  • congestion
Show 126 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorders
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • distension
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm skin peeling
  • hemolysis
  • facial swelling
  • fever
  • orthostatic effect
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • appetite loss
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory loss
  • decreased libido
  • memory impairment
  • migraine
  • neuralgia
  • sensory disturbance
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • narcolepsy
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • purpura
  • erythema
  • flushing
  • photosensitivity reaction
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning and pain in the eyes
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • vision loss
  • erectile dysfunction
  • enuresis
  • frequent urination
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • liver dysfunction
  • hepatitis
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • myalgia
  • weakness
  • elevated creatine kinase
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythema multiforme
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beats
  • arrhythmia
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and moisture, so it must be stored in a tightly closed container. The recommended storage temperature is room temperature between 1°C and 30°C. Proper storage ensures the effectiveness and safety of the medication for a longer period.

Appearance and packaging

Appearance

White, droplet-shaped film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.